ATLANTA–(BUSINESS WIRE)–Thomas Aller, OD, FBCLA, an internationally recognized expert in nearsightedness in children, has presented updated findings from a prospective clinical trial of NaturalVue® (etafilcon A) 1 Day Multifocal Contact Lenses from V…
Category: Business
Glaukos Corporation Announces Third Quarter 2018 Financial Results
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies desig…
Glaukos Corporation Announces Third Quarter 2018 Financial Results
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies desig…
Kala Pharmaceuticals to Present at the Jefferies 2018 London Healthcare Conference
WALTHAM, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY™ mucus-penetrating particle (MPP) Drug Delivery Techn…
Kala Pharmaceuticals to Present at the Jefferies 2018 London Healthcare Conference
WALTHAM, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY™ mucus-penetrating particle (MPP) Drug Delivery Techn…
Ocular Therapeutix™ Reports Third Quarter 2018 Financial Results and Business Update
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced financ…
Ocular Therapeutix™ Reports Third Quarter 2018 Financial Results and Business Update
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced financ…
Aerie Pharmaceuticals to Present at the Stifel 2018 Healthcare Conference
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Adjustable 3D Effect in Endoscopic Surgery
TAICHUNG, Taiwan–(BUSINESS WIRE)–#3D–There is a common belief that 3D visualization provides a better image to minimally invasive surgery with depth perception. MedicalTek believes that: the even better solution is the 3D image with adjustable dispa…
Aerie Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Eye Health America Completes Acquisition of Tampa Bay-Based Updegraff Laser Vision
ATLANTA–(BUSINESS WIRE)–Eye Health America (EHA), a leader in eye care practice management, today announced its sixth acquisition of the year, adding Updegraff Laser Vision to its roster of prominent eye care member practices in the Southeast United …
Omeros Corporation to Announce Third Quarter 2018 Financial Results on November 9, 2018
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (NASDAQ: OMER) today announced that the company will issue its third quarter 2018 financial results for the period ended September 30, 2018, on Friday, November 9, 2018, before the market opens. Omeros manag…
Photochromic Lenses: Global Market Analysis, Trends, Size and Forecasts to 2024 — 3.7% CAGR is Projected; Discomfort Related to Use is Hindering Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Photochromic Lenses Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024” report has been added to ResearchAndMarkets.com’s offering. The report predicts the global photochromic lenses market to g…
King Children Launches to Deliver 3D-Printed Customized Eyewear That Embraces the Diversity of Every Face
NEW YORK–(BUSINESS WIRE)–Using Apple’s True Depth hardware, customers can design glasses uniquely tailored to their facial features and personal styles for an effortless fit
STAAR Surgical ICL Sales Up 46%; Company Raises Outlook for Full Year 2018
MONROVIA, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the third quarter ended Sept…
Ocular Therapeutix™ To Report Third Quarter 2018 Financial Results
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that i…
Aerpio Pharmaceuticals to Announce Third Quarter 2018 Financial Results and Host Conference Call on Wednesday, November 7, 2018
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (NASDAQ:ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced that its third quarter 2018 fin…
Ophthotech Reports Third Quarter 2018 Financial and Operating Results
NEW YORK–(BUSINESS WIRE)–Ophthotech announced financial and operating results for the third quarter ended September 30, 2018 and provided a business update.
Ophthotech Expands Gene Therapy Pipeline in Orphan Retinal Diseases with Exclusive Option for Novel Product Candidates to Treat Best Vitelliform Macular Dystrophy (Best Disease)
NEW YORK–(BUSINESS WIRE)–Ophthotech enters into an exclusive agreement with Penn and UFRF for rights to negotiate to develop and commercialize novel AAV gene therapies
Ophthotech Expands Innovative Retinal Disease Pipeline with Acquisition of Versant Ventures’ Inception 4
NEW YORK–(BUSINESS WIRE)–Ophthotech has acquired Inception 4, Inc., a company backed by Versant Ventures, expanding its pipeline in age-related retinal indications